Search Results - "van Rees, Dieke J"

Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis by Matlung, Hanke L., Babes, Liane, Zhao, Xi Wen, van Houdt, Michel, Treffers, Louise W., van Rees, Dieke J., Franke, Katka, Schornagel, Karin, Verkuijlen, Paul, Janssen, Hans, Halonen, Pasi, Lieftink, Cor, Beijersbergen, Roderick L., Leusen, Jeanette H.W., Boelens, Jaap J., Kuhnle, Ingrid, van der Werff Ten Bosch, Jutte, Seeger, Karl, Rutella, Sergio, Pagliara, Daria, Matozaki, Takashi, Suzuki, Eiji, Menke-van der Houven van Oordt, Catharina Willemien, van Bruggen, Robin, Roos, Dirk, van Lier, Rene A.W., Kuijpers, Taco W., Kubes, Paul, van den Berg, Timo K.

“…Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be…”
Get full text

G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment by Martinez Sanz, Paula, van Rees, Dieke J, van Zogchel, Lieke M J, Klein, Bart, Bouti, Panagiota, Olsman, Hugo, Schornagel, Karin, Kok, Ivana, Sunak, Ali, Leeuwenburg, Kira, Timmerman, Ilse, Dierselhuis, Miranda P, Kholosy, Waleed M, Molenaar, Jan J, van Bruggen, Robin, van den Berg, Timo K, Kuijpers, Taco W, Matlung, Hanke L, Tytgat, Godelieve A M, Franke, Katka

“…BackgroundCurrent immunotherapy for patients with high-risk neuroblastoma involves the therapeutic antibody dinutuximab that targets GD2, a ganglioside…”
Get full text

Impaired killing of Candida albicans by granulocytes mobilized for transfusion purposes: a role for granule components by Gazendam, Roel P, van de Geer, Annemarie, van Hamme, John L, Tool, Anton T J, van Rees, Dieke J, Aarts, Cathelijn E M, van den Biggelaar, Maartje, van Alphen, Floris, Verkuijlen, Paul, Meijer, Alexander B, Janssen, Hans, Roos, Dirk, van den Berg, Timo K, Kuijpers, Taco W

“…Granulocyte transfusions are used to treat neutropenic patients with life-threatening bacterial or fungal infections that do not respond to anti-microbial…”
Get full text

Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex by van Rees, Dieke J, Bouti, Panagiota, Klein, Bart, Verkuijlen, Paul J H, van Houdt, Michel, Schornagel, Karin, Tool, Anton T J, Venet, David, Sotiriou, Christos, El-Abed, Sarra, Izquierdo, Miguel, Guillaume, Sébastien, Saura, Cristina, Di Cosimo, Serena, Huober, Jens, Roylance, Rebecca, Kim, Sung-Bae, Kuijpers, Taco W, van Bruggen, Robin, K van den Berg, Timo, Matlung, Hanke L

“…BackgroundNeutrophils kill antibody-opsonized tumor cells using trogocytosis, a unique mechanism of destruction of the target plasma. This previously unknown…”
Get full text

Immunoreceptors on neutrophils by van Rees, Dieke J, Szilagyi, Katka, Kuijpers, Taco W, Matlung, Hanke L, van den Berg, Timo K

“…Highlights • Neutrophil activities must be tightly controlled to maintain immune homeostasis. • Activating and inhibitory receptors balance the outcome of…”
Get full text

Genetic variation of human neutrophil Fcγ receptors and SIRPα in antibody‐dependent cellular cytotoxicity towards cancer cells by Treffers, Louise W., Zhao, Xi Wen, der Heijden, Joris, Nagelkerke, Sietse Q., Rees, Dieke J., Gonzalez, Patricia, Geissler, Judy, Verkuijlen, Paul, Houdt, Michel, Boer, Martin, Kuijpers, Taco W., van den Berg, Timo K., Matlung, Hanke L.

“…The efficacy of cancer therapeutic antibodies varies considerably among patients. Anti‐cancer antibodies act through different mechanisms, including…”
Get full text

Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al by Martinez Sanz, Paula, van Rees, Dieke J, Matlung, Hanke L, Tytgat, Godelieve A M, Franke, Katka

“…Correspondence to Paula Martinez Sanz; p.martinezsanz@sanquin.nl Dear Editor, We appreciate the interest of Dr Mora and Dr Chantada1 in our recently published…”
Get full text

Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20–opsonized B cells to neutrophil killing by van Rees, Dieke J., Brinkhaus, Maximilian, Klein, Bart, Verkuijlen, Paul, Tool, Anton T.J., Schornagel, Karin, Treffers, Louise W., van Houdt, Michel, Kater, Arnon P., Vidarsson, Gestur, Gennery, Andrew R., Kuijpers, Taco W., van Bruggen, Robin, Matlung, Hanke L., van den Berg, Timo K.

“…Anti-CD20 antibodies such as rituximab are broadly used to treat B-cell malignancies. These antibodies can induce various effector functions, including immune…”
Get full text